Pfizer Trial Could Take Akili Game Platform Into Digital Health Mainstream
This article was originally published in The Pink Sheet Daily
Akili Interactive plans rigorous clinical trials for its mobile gaming app “Project EVO,” amassing empirical observations in the context of the mainstream medical enterprise, where developers believe it will be effective as both a clinical tool and a therapeutic.
You may also be interested in...
Investors and their limited partners really don’t like risk, especially not the kind due to uncertainty. Now, for developers of mobile health applications and their investors, at least one risk has been taken off the table: regulatory uncertainty. On September 23, the FDA published the much-anticipated final guidance on mobile medical apps.
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.
President Obama’s proposed $56 billion Opportunity, Growth and Security Initiative would add nearly $1 billion to the NIH budget but it is funded by offsets that are likely nonstarters in Congress.